📣 VC round data is live. Check it out!
- Public Comps
- CVRx
CVRx Valuation Multiples
Discover revenue and EBITDA valuation multiples for CVRx and similar public comparables like Owlet, MEZOO, Viromed Medical, EBR Systems and more.
CVRx Overview
About CVRx
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Founded
2000
HQ

Employees
223
Website
Financials (LTM)
EV
$147M
Valuation Multiples
Start free trialCVRx Financials
CVRx reported last 12-month revenue of $60M and negative EBITDA of ($43M).
In the same LTM period, CVRx generated $51M in gross profit, ($43M) in EBITDA losses, and had net loss of ($53M).
Revenue (LTM)
CVRx P&L
In the most recent fiscal year, CVRx reported revenue of $57M and EBITDA of ($44M).
CVRx is unprofitable as of last fiscal year, with gross margin of 85%, EBITDA margin of (77%), and net margin of (94%).
Financial data powered by Morningstar, Inc.
CVRx Stock Performance
CVRx has current market cap of $160M, and enterprise value of $147M.
Market Cap Evolution
CVRx's stock price is $6.01.
CVRx share price decreased by 19.9% in the last 30 days, and by 9.3% in the last year.
CVRx has an EPS (earnings per share) of $-2.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $147M | $160M | 1.5% | -19.9% | -26.3% | -9.3% | $-2.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCVRx Valuation Multiples
CVRx trades at 2.4x EV/Revenue multiple, and (3.4x) EV/EBITDA.
EV / Revenue (LTM)
CVRx Financial Valuation Multiples
As of May 20, 2026, CVRx has market cap of $160M and EV of $147M.
CVRx has a P/E ratio of (3.0x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified CVRx Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


CVRx Margins & Growth Rates
CVRx grew revenue by 15% but EBITDA decreased by 5% in the last fiscal year.
In the most recent fiscal year, CVRx reported gross margin of 85%, EBITDA margin of (77%), and net margin of (94%).
CVRx Margins
CVRx Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
CVRx Operational KPIs
CVRx's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.4M for the same period.
CVRx's Rule of 40 is (48%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CVRx's Rule of X is (25%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
CVRx Competitors
CVRx competitors include Owlet, MEZOO, Viromed Medical, EBR Systems, Edap TMS, Apyx Medical, EKF Diagnostics, Sisram Medical, Aroa Biosurgery and Guerbet.
Most CVRx public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.5x | 1.4x | 78.3x | 41.0x | |||
| — | 22.7x | — | — | |||
| — | 7.5x | (657.4x) | 50.9x | |||
| 119.4x | 26.8x | (4.5x) | (3.9x) | |||
| 2.4x | 2.4x | (8.0x) | (7.7x) | |||
| 3.3x | 3.1x | (45.4x) | (44.2x) | |||
| 2.0x | 2.0x | 8.1x | 8.0x | |||
| 0.4x | 0.4x | 3.0x | 3.6x | |||
This data is available for Pro users. Sign up to see all CVRx competitors and their valuation data. Start Free Trial | ||||||
CVRx Funding History
Before going public, CVRx raised $185M in total equity funding, across 4 rounds.
CVRx Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout CVRx
| When was CVRx founded? | CVRx was founded in 2000. |
| Where is CVRx headquartered? | CVRx is headquartered in United States. |
| How many employees does CVRx have? | As of today, CVRx has over 223 employees. |
| Who is the CEO of CVRx? | CVRx's CEO is Kevin Hykes. |
| Is CVRx publicly listed? | Yes, CVRx is a public company listed on Nasdaq. |
| What is the stock symbol of CVRx? | CVRx trades under CVRX ticker. |
| When did CVRx go public? | CVRx went public in 2021. |
| Who are competitors of CVRx? | CVRx main competitors include Owlet, MEZOO, Viromed Medical, EBR Systems, Edap TMS, Apyx Medical, EKF Diagnostics, Sisram Medical, Aroa Biosurgery, Guerbet. |
| What is the current market cap of CVRx? | CVRx's current market cap is $160M. |
| What is the current revenue of CVRx? | CVRx's last 12 months revenue is $60M. |
| What is the current revenue growth of CVRx? | CVRx revenue growth (NTM/LTM) is 16%. |
| What is the current EV/Revenue multiple of CVRx? | Current revenue multiple of CVRx is 2.4x. |
| Is CVRx profitable? | No, CVRx is not profitable. |
| What is the current EBITDA of CVRx? | CVRx has negative EBITDA and is not profitable. |
| What is CVRx's EBITDA margin? | CVRx's last 12 months EBITDA margin is (72%). |
| What is the current EV/EBITDA multiple of CVRx? | Current EBITDA multiple of CVRx is (3.4x). |
| What is the current FCF of CVRx? | CVRx's last 12 months FCF is ($38M). |
| What is CVRx's FCF margin? | CVRx's last 12 months FCF margin is (63%). |
| What is the current EV/FCF multiple of CVRx? | Current FCF multiple of CVRx is (3.9x). |
| How many companies CVRx has acquired to date? | CVRx hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies CVRx has invested to date? | CVRx hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to CVRx
Lists including CVRx
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.